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Purpose: To determine whether magnetization transfer (MT) mag-
netic resonance (MR) imaging may serve as a quantitative 
measure of the degree of fiber formation during differen-
tiation of muscle precursor cells into engineered muscle 
tissue as a potential noninvasive monitoring tool in mice.
Materials and 
Methods:
The study was approved by the local ethics committee 
(no. StV 01/2008) and the local Veterinary Office (license 
no. 99/2013). Human muscle progenitor cells (hMPCs) 
derived from rectus abdominis muscles were subcuta-
neously injected into CD-1 nude mice (CD-1 nude mice, 
Crl:CD1-Foxn1nu; Charles River Laboratories, Wilming-
ton, Mass) for development of muscle tissue. The mice 
underwent MR imaging examinations at 4.7 T at days 1, 
3, 7, 14, 21, and 28 after cell transplantation by using a 
gradient-echo sequence with an MT prepulse and system-
atic variation of the off-resonance frequency (50–37 500 
Hz) at an amplitude of 800°. Direct saturation was esti-
mated from a Bloch equation simulation. The MT ratio 
(MTR) was correlated to immunohistochemistry findings, 
Western blot results, and results of myography. Data were 
analyzed by using one-way or two-way analysis of variance 
with the Sidak or Tukey multiple comparisons test.
Results: In the reference skeletal muscle, highest MT was found 
for 2500 Hz off-resonance frequency with an MTR 6 stan-
dard deviation of 57.5% 6 3.5. The developing muscle 
tissue exhibited increasing MT values during the 28 days 
of myogenic in vivo differentiation and did not reach the 
values of native skeletal muscle. Mean values of MTR 
(2500 Hz) for hMPCs were 27.6% 6 6.3 (day 1), 24.7% 6 
8.7 (day 3), 28.2% 6 5.7 (day 7), 35.9% 6 5.0 (day 14), 
37.0% 6 7.9 (day 21), and 39.9% 6 8.1 (day 28). The 
results from MT MR imaging correlated qualitatively well 
with muscle tissue expression of specific skeletal markers, 
as well as muscle contractility.
Conclusion: MT MR imaging may be used to noninvasively monitor 
the process of myogenic in vivo differentiation of hMPCs 
as a biomarker of the quantity and quality of muscle fiber 
formation.
q RSNA, 2016
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evaluate important aspects of muscle 
tissue formation and structure, as well 
as associated diseases (19,22).
The aim of our study was to de-
termine whether MT MR imaging may 
serve as a quantitative measure of the 
degree of fiber formation during differ-
entiation of muscle precursor cells into 
engineered muscle tissue as a potential 
noninvasive monitoring tool in mice.
Materials and Methods
Study Design
Human MPCs (hMPCs) were subcuta-
neously injected at the back of nude 
mice and examined via MR imaging af-
ter 1, 3, 7, 14, 21, and 28 days, with 
subsequent tissue harvest at days 14 
and 28 for immunohistochemistry 
analysis; hematoxylin-eosin and Mas-
son trichrome staining at days 7, 14, 
and 28 for Western blot analysis; and 
myography at day 28. The number of 
mice comprised 17 animals for three 
experimental series for MT imaging (n 
= 6, n = 5, and n = 6), two additional 
mice for Western blot analysis only, and 
four additional mice for organ bath. 
Each experimental assay (histologic ex-
amination, Western blot analysis, and 
damaged sphincter function (11). Also, 
research on the use of MPCs demon-
strated a clinical improvement in pa-
tients with urinary incontinence, and 
none of the patients showed signs of re-
jection (12). Unfortunately, the success 
of such a cell therapy approach is diffi-
cult to evaluate, as it relies on indirect 
measures, including pre- and postinjec-
tion pad tests, a diary of incontinence 
episodes, and quality of life surveys.
Strategies to directly evaluate cell 
therapies include biopsies, as well as 
several imaging modalities, including 
optical imaging, radionuclide imaging, 
and magnetic resonance (MR) imaging 
(13). While biopsies provide tissue sam-
ples that can be analyzed histologically, 
they are invasive procedures that offer 
limited sample size. The aforemen-
tioned imaging modalities can nonin-
vasively image the entire newly formed 
tissue over time. However, they gener-
ally require direct or indirect labeling of 
the cells to be injected (13). In MR im-
aging, it has been shown that MPCs can 
be monitored over time when labeled 
with magnetic nanoparticles (14,15). 
While the signal void artifact produced 
by the magnetic nanoparticles enables 
the assessment of cell engraftment, it 
inherently prevents monitoring of MR-
specific tissue properties.
Muscle tissue exhibits numerous 
traits on MR images that are highly 
specific for this particular tissue type 
(16,17). In a recent study, the devel-
opment of nonlabeled MPCs into adult 
skeletal muscle tissue was monitored 
by measuring relaxation and diffusion 
properties, which demonstrated that 
the maturing tissue develops MR char-
acteristics similar to those of mature 
skeletal muscle (18). While these pa-
rameters indirectly show the degree 
and correct direction of differentiation, 
as well as viability of the MPCs during 
tissue formation, they lack quantita-
tive information on the degree of fiber 
formation.
It has been shown previously that 
magnetization transfer (MT) imaging 
is not only a valuable method to mon-
itor diseases such as multiple sclero-
sis (19,20) or bowel fibrosis in Crohn 
disease (21), but it can also be used to 
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Advances in Knowledge
 n In developing muscle tissue, de-
creasing signal intensity when 
applying a magnetization transfer 
(MT) prepulse can be observed 
from day 1 to day 28.
 n Evaluation of the MT ratio of the 
developing muscle tissue showed 
that values reached a plateau on 
day 21, being, at an offset 
frequency of 1750 Hz, 70% of 
the skeletal muscle reference, 
with little to no increase by day 
28.
 n Calculation of the true MT 
(MTtrue) from experimental 
results by using numerical simu-
lations showed that, after an ini-
tial peak at day 1, maximum 
MTtrue increased over time, with 
27.6% at 750 Hz, 28.4% at 750 
Hz, 32.0% at 2500 Hz, 32.2% at 
2500 Hz, and 33.9% at 2500 Hz 
at days 3, 7, 14, 21, and 28, 
respectively.
The quality of life of patients with urinary incontinence is markedly compromised (1). A conservative 
estimate is that urinary incontinence af-
fects approximately 20% of women, but 
in fact, the prevalence may be as high 
as 50% in elderly women (2). Care of 
patients with urinary incontinence in-
curs annual direct costs of $16 billion in 
the United States (3), and demographic 
changes will increase the economic 
burden posed to society. Current treat-
ment options for urinary incontinence 
show great patient-to-patient variability 
and only limited success overall (1).
Cell-based therapies have been pro-
posed as a method to achieve restora-
tion of numerous urogenital tissues and 
organs (4–6), with the transplantation 
of muscle progenitor cells (MPCs) hav-
ing shown great potential as a treat-
ment for genetic and acquired muscle 
disorders (7,8). Investigations on the 
injection of in vitro culture–expanded 
MPCs for the treatment of urinary in-
continence in small animal models were 
promising (9,10), with results obtained 
in dogs demonstrating that MPCs are 
able to restore otherwise irreversibly 
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without a systematic variation of the 
MT prepulse (off-resonance frequency, 
10–100 000 Hz; and flip angles of 300°, 
600°, 1200°, or 2400°).
Calculation of the MT Ratio and 
Simulation of Direct Saturation Effects
The MT ratio (MTR), calculated as 
MTR = (M0 2 MSAT)/M0, where M0 rep-
resents the equilibrium magnetization 
(MR signal intensity) without MT pulse 
and MSAT represents the magnetization 
with MT prepulse, was calculated as a 
quantitative measure of the interaction 
of the macromolecular pool with the liq-
uid pool. MTR values from the acquired 
images were calculated pixelwise on a 
stand-alone computer by using an in-
house–developed routine written in the 
Matlab programming language (Math-
Works, Natick, Mass). Since the in-
jected collagen and cell volume showed 
a strong decrease over time, drawing 
of a reasonable region of interest for 
MTR evaluation was not possible in all 
animals or for all injections. For MTR 
analysis, 15 injections in eight mice ful-
filled this criterion at day 21, and eight 
injections in four mice fulfilled this cri-
terion at day 28. Simulation of direct 
saturation effects was performed by 
using a custom-written C++ program 
(kindly provided by Fritz Schick, Uni-
versity Hospital Tübingen, Tübingen, 
Germany) as described previously (24). 
On the basis of the settings obtained 
from the MR imaging unit, the used 
routine encompassed a wait time of 
115 msec, followed by a radiofrequency 
pulse (Gaussian shape, 800° angle, and 
10.9-msec duration, directly followed 
by a 226-µsec MT spoiler gradient 
[100%] and a gap of 228 µsec to the 
start of the section-encoding gradients 
with off-resonance frequencies of 50–
10 000 Hz; direct saturation larger than 
10 000 Hz is negligible), a wait time of 
1519 µsec, followed by a radiofrequency 
pulse (sinc shape; 12° angle; 1-msec 
duration with spoiler gradients of the 
imaging sequence starting 5986 µsec 
after the center of the excitation pulse; 
read spoiler duration, 1 msec [30%]; 
and section spoiler duration, 1.2 msec 
[40%]). This routine was repeated 512 
times (reaching equilibrium typically at 
(passage 3) after initial isolation, washed 
with phosphate-buffered saline (Gibco 
and Invitrogen), and suspended in 1.5% 
collagen type I solution (BD Biosci-
ences, Two Oak Park, Bedford, Mass). 
Animals were anesthetized with 3% 
isoflurane (1-Chlor-2,2,2-trifluorethyl-
difluoromethylether; Attane, Minrad, 
Buffalo, NY), and 3 3 107 hMPCs were 
injected on the left and right sides of 
the lower back of the nude mice.
MR Imaging
Mice were subjected to MR imaging 
analysis 1, 3, 7, 14, 21, and 28 days 
after hMPC transplantation. During 
the imaging process, mice were anes-
thetized with 1.5% isoflurane. All 
measurements were performed with a 
Bruker 4.7-T Pharmascan 47/16 unit 
(Bruker BioSpin MRI, Ettlingen, Ger-
many) equipped with a linear polarized 
hydrogen 1 mouse whole-body trans-
mit-receive radiofrequency coil. After 
a gradient-echo localizer image was ac-
quired in three spatial directions, the 
T2-weighted morphologic MR images 
were acquired by using a rapid acqui-
sition with relaxation enhancement 
sequence (repetition time [msec]/echo 
time [msec], 2500/11; rapid acquisi-
tion with relaxation enhancement fac-
tor, eight; number of signals acquired, 
three; section thickness, 1 mm; field of 
view, 40 3 40 mm; matrix, 256 3 256; 
and acquisition time, 4 minutes). For 
MT measurements, a three-dimension-
al spoiled gradient-echo sequence (fast 
low-angle shot; 20.4/4.7; number of 
signals acquired, two; field of view, 40 
3 30 3 30 mm; matrix, 128 3 128 3 
64; spatial resolution, 0.31 3 0.23 3 
0.47; excitation flip angle, 12°; receiver 
bandwidth, 50 000 Hz; sinc excitation 
pulse, 1 msec; and acquisition time, 5 
minutes 35 seconds) was applied with 
and without a systematic variation 
of the MT prepulse (Gaussian pulse 
shape, applied for each repetition time; 
off-resonance frequency, 50–37 500 Hz; 
flip angle, 800°; duration, 10.9 msec; 
bandwidth, 250 Hz; no dummy pulses). 
For the validation of the MT proto-
col and the sequence simulation, the 
same three-dimensional spoiled gradi-
ent-echo sequence was used with and 
organ bath) was performed at least 
three times. All animal experiments 
were approved by the local veterinary 
authorities (Veterinary Office of the 
Department of Health of the Canton of 
Zurich, license no. 99/2013).
Cell Culture
hMPCs were derived from rectus ab-
dominis muscle samples obtained from 
patients undergoing abdominal surgery 
after providing informed consent, which 
was approved by the local ethics com-
mittee (ethics committee of the Canton 
of Zurich, no. StV 01/2008). The cells 
were isolated and cultured according to 
protocols described previously (11,23). 
In brief, muscle biopsy samples were 
minced and digested for 40 minutes at 
37°C and 5% CO2 in Dulbecco’s Mod-
ified Eagle’s Medium (Gibco, Grand 
Island, NY) and F12 nutrient mixture 
(Invitrogen, Carlsbad, Calif) supple-
mented with 0.4% dispase (Gibco) and 
0.2% collagenase type I (Worthington 
Biochemical, Lakewood, NJ). To reduce 
the number of fast-adhering fibroblasts, 
the digested samples were centrifuged, 
filtered, and plated on collagen type I 
coated six-well dishes for 24 hours be-
fore transferring the hMPC-containing 
suspension to fresh collagen type I 
coated six-well dishes. The cells were 
cultivated at 37°C and 5% CO2 with 
growth medium (Dulbecco’s Modified 
Eagle’s Medium [Gibco] and F12 nutri-
ent mixture [Invitrogen]); supplemented 
with 18% fetal bovine serum (Gibco and 
Invitrogen), 1% penicillin and strepto-
mycin (Gibco and Invitrogen), 10 µg/mL 
human epidermal growth factor (Sigma, 
Buch, Switzerland), 1 µg/mL human ba-
sic fibroblast growth factor (Sigma), 10 
µg/mL human insulin (Sigma), and 0.4 
µg/mL dexamethasone (Sigma); and 
harvested and subcultivated on stan-
dard tissue culture polystyrene dishes 
when reaching 80%–90% confluency.
Cell Injection
hMPCs were injected into the subcuta-
neous space of the back of female nude 
mice (CD-1 nude mice, Crl:CD1-Foxn-
1nu; Charles River Laboratories, Wilm-
ington, Mass). Prior to the injection, 
the cells were subcultivated three times 
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comparisons test (for myography data) 
or two-way analysis of variance with 
the Tukey multiple comparisons test 
(for Western blot analysis data from 
one time point to all other time points 
for all proteins and days and for MTR 
values from one time point to all other 
time points for all offset frequencies 
and days). The results are presented 
as mean values 6 standard deviations, 
and data with a P value less than .05 
were considered to indicate a signifi-
cant difference.
Results
Morphologic MR Imaging and MT Image 
Contrast
Typical MR imaging images of mice af-
ter hMPC transplantation are displayed 
in Figure E1 (online) at three different 
time points. T2-weighted images dis-
play the sites of injection and the subse-
quent decrease in injected volume over 
28 days. Moreover, it can be seen that 
the signal intensities of the hMPCs de-
crease during differentiation, indicating 
a decrease in the respective T2 trans-
verse relaxation time. On the MT im-
ages, it can be observed that the signal 
intensity of tissues decreases compared 
with the images without MT prepulse, 
except for fatty tissue. At low MT off-
resonance frequency (50 Hz), this ef-
fect is predominantly caused by direct 
saturation (assessment of direct satura-
tion is further described herein). At off-
resonance frequencies of 1750 Hz and 
higher, true MT is visible with signal in-
tensity primarily in the area of skeletal 
muscle. Regarding the signal intensity 
of the hMPCs, no change in signal in-
tensity from day 1 to day 14 without 
application of an MT prepulse is visible. 
However, decreasing signal intensity 
when applying an MT prepulse can be 
observed from day 1 to day 14, irre-
spective of the chosen offset frequency. 
The acquired signal intensity further 
decreased from day 14 to day 28 with 
applied prepulse for all off-resonance 
frequencies; but also a minor change in 
signal intensity could be observed with-
out prepulse (which is due to a change 
in the relaxation properties, as shorter 
was loaded on a 12% gel (Bio-Rad, 
Cressier, Switzerland). The separated 
proteins were electrotransferred onto a 
polyvinylidene fluoride membrane (Im-
mobilion-P; Millipore, Bedford, Mass). 
The membranes were incubated with 
primary antibodies against MyHC (1:2, 
Developmental Studies Hybridoma 
Bank), a-actinin (1:2000, Sigma), des-
min (1:500, Sigma), and monoclonal 
glyceraldehyde-3-phosphate dehydroge-
nase (1:2500, Sigma) in Tris-buffered 
saline with 0.1% Tween-20 (Sigma) and 
5% nonfat dry milk overnight at 4°C. 
The membranes were subsequently 
washed and incubated with the appro-
priate horseradish peroxidase–conju-
gated secondary antibody (1:6000, Am-
ersham Pharmacia Biotech, Dübendorf, 
Switzerland) in Tris-buffered saline and 
Tween 20 (Sigma) for 1 hour at room 
temperature. The signals on the mem-
branes were detected by using the elec-
trochemiluminescence method (ECL 
Kit, Amersham Pharmacia Biotech) 
and analyzed by using Image Studio 
Lite (Li-Cor, Lincoln, Neb) software, 
with the intensity of each band of inter-
est being normalized to glyceraldehyde-
3-phosphate dehydrogenase.
Myography to Assess Muscle Tissue 
Contractility
Contractility of the newly formed tis-
sues was evaluated with myography 4 
weeks after hMPC injection. The ex-
cised muscle strips were fastened with 
suture loops to the transducer in tissue 
bath chambers and were immersed in 
Krebs solution (119 mmol/L NaCl, 4.4 
mmol/L KCl, 20 mmol/L NaHCO3, 1.2 
mmol/L NaH2PO4, 1.2 mmol/L MgCl2, 
2.5 mmol/L CaCl2, and 11 mmol/L glu-
cose) under constant oxygenation at 
room temperature. Muscle strips were 
treated with electrical field stimulation 
(40 Hz at 40 V and 80 Hz at 80 V), and 
contractions were recorded. The values 
were normalized to the sample weight 
(milligram per milligram of tissue).
Statistics
Experiments were repeated with at 
least three human samples. Data were 
analyzed by using one-way analysis 
of variance with the Sidak multiple 
80–100 iterations) by using previously 
published T1 and T2 values (18). Direct 
saturation effects (MTdir in the following 
equation) were quantified as the reduc-
tion of transverse magnetization due 
to the MT pulse in the MR sequence 
MTdir = S0 2 SMT/S0, with S0 meaning 
the transverse magnetization after the 
first excitation and SMT meaning the 
transverse magnetization after equilibra-
tion of the sequence. True MT (MTtrue) 
was subsequently calculated from the 
experimental MTR by subtracting the 
direct saturation effects that resulted 
from direct saturation.
Histologic Examination to Assess Muscle 
Tissue Formation and Muscle Marker 
Expression
The mice were sacrificed 14 and 28 days 
after cell injection, and the tissue-engi-
neered muscles were excised from their 
backs, frozen, and sectioned at 10 µm. 
Hematoxylin-eosin and Masson tri-
chrome staining were performed with 
the frozen sections from the different 
time points to assess muscle tissue 
formation. For immunohistochemistry 
analysis, tissue sections were incubated 
with primary mouse antibody against hu-
man myosin heavy chain (MyHC) (1:1) 
overnight at 4°C and secondary rabbit 
antimouse antibody cyanine 3 immuno-
globulin G (1:1000) together with 49,6-di-
amidine-2-phenylindole·dihydrochloride 
(1:100) at room temperature for 1 hour.
Western Blot Analysis to Assess Muscle 
Marker Expression
Seven, 14, and 28 days after hMPC in-
jection, the newly formed muscle tis-
sues were harvested and frozen. For 
Western blot analyses, the samples 
were powderized in liquid nitrogen and 
lysed with lysis buffer that contained 
50 mmol/L Tris-HCl, with a pH level of 
7.4, 150 mmol/L NaCl, 10% glycerol, 
1% Triton X-100 (Sigma), 2 mmol/L 
ethylenediaminetetraacetic acid, 50 
mmol/L sodium fluoride, 200 µmol/L 
sodium orthovanadate, and protease 
inhibitor cocktail (Sigma-Aldrich). The 
total protein content of each lysate was 
quantified with the BCA Protein As-
say Kit (Thermo Scientific, Lausanne, 
Switzerland), and 30 µg per sample 
Radiology: Volume 000: Number 0—   2016 n radiology.rsna.org 5
EXPERIMENTAL STUDIES: Magnetization Transfer MR Imaging: in Vivo Differentiation of Muscle Precursor Cells Rottmar et al
water does not show any MT, the signal 
intensity obtained must reflect pure di-
rect saturation. An excellent correspon-
dence between simulation and mea-
surement data can be seen in Figure E3 
(online).
Quantitative Evaluation of MT Ratios
Curves of the mean MT ratios in depen-
dence of the off-resonance frequency 
are depicted in Figure 1 for hMPCs 
frequencies on the order of 100%. With 
increasing off-resonance frequency, the 
MT ratios exhibited a monotone decline 
asymptotically, reaching zero at off-res-
onance frequencies higher than 50 kHz. 
A characteristic shoulder can be seen at 
2–20 kHz for 600° and 1200° flip angle.
The accuracy of the Bloch equation 
simulation was assessed by means of 
comparison to experimental MTR mea-
surements in a water phantom. Since 
T2* time causes a signal intensity de-
crease with a gradient-echo sequence).
Validation of the MT Protocol and 
Sequence Simulation
The experimental setup of the MT MR 
imaging measurements was validated in 
phantom experiments with 4% agarose. 
The corresponding MTRs are depicted 
in Figure E2 (online). Highest MT ratios 
were observed for small off-resonance 
Figure 1
Figure 1: Graphs show MTR as a function of offset frequencies. hMPCs were injected into the subcutaneous space of nude mice 
and evaluated with MT MR imaging over the time course of 28 days. (a) Day 1, (b) day 3, (c) day 7, (d) day 14, (e) day 21, and (f) day 
28 values are shown. MTR of hMPCs (n = 8–15) was plotted as a function of offset frequencies, and values of the previous time point 
(dashed line) were included in each graph to visualize progressive changes. Skeletal muscle (n = 43) was used as a reference. ∗ 5 
P , .05 (statistically significant) when compared with the previous time point, ∗∗ = P , .01 (statistically significant) when compared 
with the previous time point.
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28.4% at 750 Hz, 32.0% at 2500 Hz, 
32.2% at 2500 Hz, and 33.9% at 2500 
Hz at days 1, 3, 7, 14, 21, and 28, re-
spectively. The development of MTtrue 
over time is shown for an offset fre-
quency of 2500 Hz in Figure 2c, and 
values were found to reach 68.8% of 
the MTtrue of skeletal muscle.
Injected hMPCs Form Functional Muscle 
Tissue
To evaluate the newly formed muscle tis-
sue for correct morphologic appearance 
and function, histologic examination, 
immunohistochemistry analysis, West-
ern blot analysis, and myography were 
performed at different time points.
Representative images of tissue sec-
tions from two different experiments at 
days 14 and 28 that were stained with 
hematoxylin-eosin, Masson trichrome, 
or, for a specific muscle marker, MyHC, 
are shown in Figure E4 (online). Collag-
enous tissue or a mix of collagenous tis-
sue and muscle fibers could be observed 
at day 14, with an increasing amount 
of muscle fibers apparent by day 28. 
Muscle fiber formation was confirmed 
with MyHC staining. Skeletal muscle 
was used as a reference, showing nicely 
significant. However, from days 1, 3, or 
7 to day 14 (and later time points), a 
statistically significant increase (with P 
, .05 or better) could be seen. While 
MTR values increased from day 14 to 
day 21, this increase was not statisti-
cally significant. Only a small increase 
or no increase at all could be seen from 
day 21 to day 28.
Numerical simulations were used 
to subtract direct saturation effects 
from the measured MTR values to 
obtain MTtrue (Fig 2). Experimen-
tal MTR values and calculated MTtrue 
are shown for skeletal muscle (Fig 2a). 
Calculating MTtrue for offset fre-
quencies between 50 and 10 000 Hz 
(upper limit of computation for di-
rect saturation effects) demonstrated 
increasing values, reaching 48.2% at 
2500 Hz before declining to 38.5% 
at 10 000 Hz (Fig 2b). Interestingly, 
while similar changes in MTtrue could 
be observed for injections of hMPCs 
in collagen with increasing offset 
frequencies, maximum values were ob-
served at lower offset frequencies for 
earlier time points. Maximum MTtrue 
was found to increase over time with 
36.8% at 750 Hz, 27.6% at 750 Hz, 
and the reference of skeletal muscle 
at different time points during differ-
entiation. MTR values of skeletal mus-
cle displayed a gradual decrease from 
91.8% 6 1.8 to 2.7% 6 4.4 with in-
creasing offset frequencies, resulting 
in a maximal MTR of 57.5% 6 3.5 at 
2500 Hz. At day 1, MTR values from 
87.3% 6 6.7 to 22.0% 6 5.0 were ob-
served for injections of hMPCs in colla-
gen with increasing offset frequencies, 
demonstrating much lower values in 
the midrange of offset frequencies. 
At 2500 Hz, an MTR of 27.6% 6 6.3 
for hMPCs was obtained at day 1. In-
terestingly, the MTR values showed a 
decrease from day 1 to day 3 (MTR, 
24.7% 6 8.7 at 2500 Hz) but increased 
at the following time points to an MTR 
of 28.2% 6 5.7, 35.9% 6 5.0, 37.0% 
6 7.9, and 39.9% 6 8.1 for days 7, 14, 
21, and 28, respectively. Similar chang-
es in MTR values could be observed 
for all offset frequencies between 500 
and 17 500 Hz. Notably, however, MTR 
values reached a plateau on day 21, be-
ing between 64% and 72% of the skele-
tal muscle reference, with little to no in-
crease by day 28. The increase in MTR 
values from day 1 to days 3 or 7 was not 
Figure 2
Figure 2: Graphs show calculations of true MT for myogenic in vivo differentiation over 
28 days. (a) Numerical simulation of direct saturation effects (T1, 1410 msec; T2,  
30 msec) plotted against experimental MTR values of skeletal muscle (n = 43) to show 
MT
true
. (b) Calculated MT
true
 values of injected hMPCs (day 1 MT
true
, n = 15; to day 28 
MT
true
, n = 8; with corresponding T1 and T2 values for simulations in brackets) and skeletal 
muscle as reference (refMT
true
, n = 43) as a function of offset frequencies. (c) Calculated 
MT
true
 values of injected hMPCs at an offset frequency of 2500 Hz as a function of time 
post injection (p.i.).
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other hand, consists of nonoriented 
fibers and remains of collagenous tissue, 
where no correct orientation for fixa-
tion exists. While this is probably due 
to injections in the subcutaneous space 
without structural guidance for oriented 
muscle fiber formation, it is possibly less 
relevant if hMPCs are injected into dam-
aged muscle tissue, as remaining tissue 
still provides some guidance for newly 
forming muscle fibers. Supporting this, it 
could be shown previously in a large ani-
mal model that when autologous hMPCs 
are injected into the damaged sphinc-
ter muscle, 80% of the initial sphincter 
pressure can be restored (11). Finally, 
evaluating different offset frequencies 
of the MT prepulse, the range between 
2500 and 5000 Hz could be defined to 
give optimal MT image contrast, which 
is in good agreement with previous find-
ings (29). A decrease in signal intensity 
was observed with the sequence without 
prepulse from day 14 to day 28, which 
reflects the shortening of the T2* time 
of the tissue, presumably due to lower 
water content. This decrease was con-
sidered in the calculation of the direct 
saturation effects by adjustment of the 
respective relaxation properties in the 
Bloch simulation. Therefore, the change 
in relaxation properties did not nega-
tively affect the MT quantification ac-
curacy, which is also supported by the 
stability of MTR between day 14 and 
day 28.
Our study had limitations. First, 
T1 and T2 relaxation time measure-
ments, which are required for estima-
tion of direct saturation effects, could 
not be performed in the same session 
as MT experiments because of the con-
straints regarding measurement time 
of the nude mice in one session; in-
stead, T1 and T2 data from previous 
studies have been used. Second, only 
a phenomenological description of the 
observed MT effects with increasing 
fiber content is provided. We did not 
investigate the chemical basis of the 
effect (eg, the chemical exchange pro-
cesses taking place between macromo-
lecular and liquid pool).
In conclusion, MT MR imaging 
may be used to noninvasively moni-
tor the process of myogenic in vivo 
and measurement of tissue contractil-
ity. Experimental MT measurements 
were validated by using a previously 
described agarose model (26). Both 
MTR values and MTtrue (subsequently 
referred to as “MT values”) increased 
over the investigated time period of 28 
days, reaching a plateau at day 21 with 
around 70% of native skeletal muscle. 
This increase was, however, only ob-
served after an initial decrease from 
day 1 to day 3. The initially higher MT 
values at day 1 are probably due to the 
high collagen content used for injec-
tion of the hMPCs. This is supported 
by previous work on monitoring of in-
testinal fibrosis of Crohn disease (27), 
as well as a study on pancreatic cancer 
xenografts (28), which demonstrated 
a correlation of collagen content and 
high MTR values. The decrease of MT 
values from day 1 to day 3 is likely due 
to initial remodeling and degradation of 
the injected collagen, and only after day 
3 do changes in MT values reflect the 
process of muscle fiber formation from 
injected hMPCs.
Interestingly, MT values increased 
from day 3 to day 21; however, not much 
change could be observed from day 21 to 
day 28. Reasons for these observations 
can be manifold, but incomplete muscle 
tissue formation and an unorganized 
tissue structure are likely to be major 
contributors. This is supported by histo-
logic results, which show larger areas of 
collagenous tissue along or in between 
newly formed muscle fibers at 14 and 28 
days. Also, tissue contractility assessed 
via myography demonstrated that con-
traction levels of hMPC-derived muscle 
tissue reaches only about 13%–16% of 
native muscle by day 28, which is, how-
ever, much lower compared with the 
observations with MT MR imaging (MT 
values reached around 70% those of na-
tive muscle). This discrepancy can possi-
bly be explained by the large differences 
in the structural organization of the as-
sessed tissue samples. The skeletal mus-
cle reference (tibialis anterior) consists 
of nicely aligned, densely packed muscle 
fibers and allows fixation of the muscle 
for myography in correct orientation by 
using the ligaments. The bioengineered 
muscle tissue from our study, on the 
aligned muscle fibers that showed posi-
tive staining for MyHC.
Western blot of the injected hMPCs 
with collagen was performed at days 7, 
14, and 28 for muscle-specific proteins 
MyHC, a-actinin, and desmin, as well 
as for glyceraldehyde-3-phosphate de-
hydrogenase as a reference protein 
(Fig E5a [online]). All muscle-specific 
proteins could be detected, displaying 
lower protein expression at day 7 and 
day 14 but much stronger expression at 
day 28. This increased expression was 
statistically significant for desmin be-
tween day 7 and day 28 but not for the 
other proteins.
Myography was performed at 
day 28 to evaluate contractility as a 
measure of tissue functionality (Fig E5b 
[online]). Two different electrical regi-
mens (40 V and 40 Hz; and 80 V and 80 
Hz) were used to monitor contraction 
levels of bioengineered muscle tissues 
with collagen-only and skeletal muscle 
(tibialis anterior) as a reference. Engi-
neered muscle tissue displayed contrac-
tion levels that reached 13%–16% of 
the skeletal muscle reference.
Discussion
MT describes the interaction of tissue-
water protons that reside in different 
environments, encompassing the “free” 
water proton pool responsible for the 
conventional MR imaging signal inten-
sity and the “restricted” proton pool 
where protons are bound to macromol-
ecules (25). Owing to the large abun-
dance of macromolecules in the form of 
aligned muscle fibers in well-developed 
muscle tissue, muscle shows higher MT 
than most other tissues of the human 
body. Therefore, MT could represent 
an ideal biomarker for characterization 
of fiber formation during muscle devel-
opment. Importantly, no MT is found in 
water because of the lack of macromol-
ecules for interaction; also, fatty tissue 
does not show MT because of a lack of 
mobile water molecules.
In our study, in vivo myogenic dif-
ferentiation of hMPCs in mice was 
monitored with MT MR imaging, and 
muscle formation was confirmed by his-
tologic findings, Western blot analysis, 
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differentiation of hMPCs as a bio-
marker of the quantity and quality of 
muscle fiber formation. While previous 
measurements of relaxation properties 
presented identical values for hMPC-
derived muscle tissue and native muscle 
(18), our results based on MT values 
ultimately allow for evaluation of mus-
cle tissue quality. On the basis of our 
findings, application of sophisticated 
MR imaging techniques seems to hold 
great promise in enabling clinical eval-
uation of the success of cell therapy 
approaches.
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